Projected Savings for Urolithiasis Medications Purchased Through the Mark Cuban Cost Plus Drug Company in Medicare

Direct-to-consumer online pharmacies offer affordable alternatives for cash-paying customers purchasing urolithiasis medications. Replacing Part D formulary with MCCPDC pricing could yield significant savings for 5 generic urolithiasis medications.

Authors

Institutions

Publication Details

Journal
Urology Practice
Published
2025-10-23
DOI
https://doi.org/10.1097/upj.0000000000000908
Primary Topic
Healthcare Policy and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Projected Savings for Urolithiasis Medications Purchased Through the Mark Cuban Cost Plus Drug Company in Medicare

Ryan S. Hsi, Brian D. Cortese, Ruchika Talwar, Amir Ishaq Khan et al.
Urology Practice
Healthcare Policy and Management
article

Projected Savings for Urolithiasis Medications Purchased Through the Mark Cuban Cost Plus Drug Company in Medicare

Ryan S. Hsi, Brian D. Cortese, Ruchika Talwar, Amir Ishaq Khan, Nicholas Kavoussi, Kimberly A. Maciolek, Linda Cox
article en

Abstract

Direct-to-consumer online pharmacies offer affordable alternatives for cash-paying customers purchasing urolithiasis medications. Replacing Part D formulary with MCCPDC pricing could yield significant savings for 5 generic urolithiasis medications.

Urology PracticeVol. 13(2)
Vanderbilt University Medical Center (US)
Openalex Percentile: Top 61%
Healthcare Policy and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.